Key result
Schizophrenia is linked to ~2.8-fold higher odds of cardiovascular autonomic neuropathy.
Why the study?
It was unknown whether schizophrenia and the duration of schizophrenia were associated with cardiovascular autonomic neuropathy using heart rate variability as a marker.
Does schizophrenia increase the risk of cardiovascular autonomic neuropathy in adult patients?
Cross-Sectional (n=420)
No
Does schizophrenia increase the risk of cardiovascular autonomic neuropathy in adult patients?
Patients with schizophrenia have a significantly higher prevalence of cardiovascular autonomic neuropathy, highlighting the potential need for early autonomic screening to mitigate cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Schizophrenia-CAN association should not yet change practice; leaves open need for longitudinal studies on screening utility.
Study objective: This study investigated whether schizophrenia and the duration of schizophrenia were associated with cardiovascular autonomic neuropathy (CAN) by using heart rate variability (HRV) as a marker. Design: Cross-sectional study. Setting: The examinations were conducted at the Centre for Psychosis Research and at the Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark. Participants: 240 patients with first-episode and chronic schizophrenia and 180 controls. Interventions: CAN was assessed by the cardiovascular reflex tests (CARTs): HR, RS ratio, E:I ratio, and VM using a handheld device. Main outcome measures: One abnormal CART was interpreted as borderline CAN and ≥2 abnormal CARTs established definitive CAN. Borderline CAN and definitive CAN together was categorized as overall CAN. Analyses were adjusted for age, sex, smoking, overweight, and hypercholesterolemia. Schizophrenia was significantly associated with overall CAN (OR, 2.80; 95%CI, 1.75-4.50), with an OR of 2.31 (95%CI, 1.14-4.68) for first-episode schizophrenia and an OR of 2.97 (95%CI, 1.81-4.87) for chronic schizophrenia. Conclusion: It was demonstrated that a diagnosis of schizophrenia was associated with CAN. Patients with chronic schizophrenia had a significantly higher prevalence of CAN compared to patients with first-episode schizophrenia, suggesting an association between the duration of schizophrenia and CAN.
No takes yet. Share an insight, caveat, or question.
Blok-Husum et al. (2023) conducted a cross-sectional in Schizophrenia (n=420). Schizophrenia vs. Healthy controls was evaluated on Overall cardiovascular autonomic neuropathy (CAN) (OR 2.80, 95% CI 1.75-4.50). Schizophrenia was significantly associated with an increased prevalence of overall cardiovascular autonomic neuropathy compared to controls (OR 2.80).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: